In the CRP PEV-treated A2058 spheroids, pathways of cell cycle, microRNAs in cancer, MAPK signaling, proteoglycans in cancer and platelet activation were significantly upregulated at 6 h compared to 24 h. This evidence concerns the gene CRP and cancer.